Report for: The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

Title	The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy
Published in	Inflammatory Bowel Diseases, April 2022
DOI	10.1093/ibd/izac071
Pubmed ID	35397000
Authors	Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman, Heidi Chapman, John C Prostko, Edwin C Frias, James L Stewart, Valeriya Pozdnyakova, Philip Debbas, Angela Mujukian, Arash A Horizon, Noah Merin, Sandy Joung, Gregory J Botwin, Kimia Sobhani, Jane C Figueiredo, Susan Cheng, Ian M Kaplan, Dermot P B McGovern, Akil Merchant, Gil Y Melmed, Jonathan Braun

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 23 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	5	22%
United Kingdom	2	9%
India	2	9%
Canada	2	9%
Ireland	1	4%
Spain	1	4%
Unknown	10	43%

Demographic breakdown

Type	Count	As %
Members of the public	16	70%
Scientists	4	17%
Practitioners (doctors, other healthcare professionals)	3	13%

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Unknown	18	100%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	3	17%
Researcher	2	11%
Student > Ph. D. Student	2	11%
Student > Doctoral Student	1	6%
Student > Master	1	6%
Other	1	6%
Unknown	8	44%

Readers by discipline	Count	As %
Medicine and Dentistry	6	33%
Immunology and Microbiology	3	17%
Pharmacology, Toxicology and Pharmaceutical Science	1	6%
Economics, Econometrics and Finance	1	6%
Unknown	7	39%

Attention Score in Context

This research output has an Altmetric Attention Score of 97. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2022.

All research outputs

#389,358

of 23,577,654 outputs

Outputs from Inflammatory Bowel Diseases

#19

of 3,551 outputs

Outputs of similar age

#10,868

of 444,245 outputs

Outputs of similar age from Inflammatory Bowel Diseases

of 49 outputs

Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 3,551 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 99% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.

We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.

Oxford University Press

Article Metrics

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context